[ 18 F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica.

Bastien AllardValérie Devauchelle-PensecAlain SarauxEmmanuel NowakAlice TisonSara BoukhlalDewi GuellecSandrine Jousse-JoulinDivi CornecThierry MarhadourRomain Le PennecPierre-Yves SalaünSolène Querellou

Published in: European journal of nuclear medicine and molecular imaging (2023)

The study was approved by the appropriate ethics committee (CPP Sud-Est II Ref CPP: 2018-33), and all patients gave their written informed consent before study enrollment. The protocol was registered on Clinicaltrials.gov (NCT03632187).

Keyphrases

early onset
end stage renal disease
randomized controlled trial
public health
late onset
newly diagnosed
chronic kidney disease
patient reported outcomes
deep learning